Article
Detecting truly clonal alterations from multi-region profiling of tumours
27 Mar 2017
Abstract excerpt
Modern cancer therapies aim at targeting tumour-specific alterations, such as mutations or neo-antigens, and maximal treatment efficacy requires that targeted alterations are present in all tumour cells. Currently, treatment decisions are based on one or a few samples per tumour, creating uncertainty on whether alterations found in those samples are actually present in all tumour cells. The probability of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
